Magee-Womens' Hospital of UPMC

Pittsburgh, Pennsylvania 15601

6 studies enrolling now · 138 studies all time

What they study most

Acceptability, Acute Pain, Adnexal Mass, Advanced Breast Cancer (Female), Advanced Solid Malignancies, Advanced Solid Tumor, Advanced, Persistent, or Recurrent Endometrial Cancer, Anesthesia, Epidural, Anti-Infective Agents, Appendiceal Adenocarcinoma, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation

Studies at this site

• A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
• Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes — Recruiting now
• Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial — Recruiting now
• Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period — Recruiting now
• Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer — Recruiting now
• Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy — Running, not enrolling
• Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer — Stopped early
• A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer — Completed
• Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery — Paused
• Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean — Completed
• Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Running, not enrolling
• Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial — Running, not enrolling
• Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia — Running, not enrolling
• STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy — Completed
• Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. — Completed
• Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Running, not enrolling
• Point of Care Diagnosis of Vaginal Infections — Completed
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer — Completed
• Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence — Running, not enrolling
• Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer — Running, not enrolling
• Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus — Running, not enrolling
• Pravastatin to Prevent Preeclampsia — Stopped early
• Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension — Completed
• DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] — Running, not enrolling
• Impact of Collaborative Care for Pregnant Women With Opioid Use Disorder in Low-Resource Obstetric Settings — Enrolling by invitation
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery — Completed
• Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1) — Completed
• Randomized Trial of Culture Directed Versus Empiric Antibiotics for Urinary Tract Infections in Older Women — Completed
• Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC — Running, not enrolling
• Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Rings — Stopped early
• A Study of SGN-STNV in Advanced Solid Tumors — Stopped early
• A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System — Completed
• Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus — Completed
• Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer — Stopped early
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer — Completed
• Cystic Fibrosis and Urinary Incontinence — Stopped early
• Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer — Completed
• Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer — Stopped early
• Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients — Stopped early
• Precision Opioid Care After Cesarean Delivery (PRECISE-CD) — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain — Stopped early
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• An Observational Study of Hepatitis C Virus in Pregnancy — Completed
• Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
• A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer — Stopped early
• Opioid Prescription After Cesarean Trial — Completed